Review



1 ap proteintech rabbit anti p nf2  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Proteintech 1 ap proteintech rabbit anti p nf2
    1 Ap Proteintech Rabbit Anti P Nf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+nf2/NF2+Antibody/pmc12361455__41419_2025_7962_MOESM4_ESM-18-81-82
    Average 93 stars, based on 24 article reviews
    1 ap proteintech rabbit anti p nf2 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting Ferroptosis
    Article Snippet: .. Then, the sections were blocked with goat serum at room temperature for 10 min, and then incubated with the primary antibodies against GPX4 (#Ab125066, Abcam), SLC7A11 (#Ab175186, Abcam), ACSL4 (#Ab155282, Abcam), ZEB1 (#Sc‐515,797, Santa Cruz Biotechnology), E‐cadherin (#20874‐1‐AP, Proteintech), p‐YAP (#29018‐1‐AP, Proteintech) and p‐NF2 (#28851‐1‐AP, Proteintech) overnight at 4°C. ..

    Article Title: DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting Ferroptosis.
    Article Snippet: .. Then, the sections were blocked with goat serum at room temperature for 10 min, and then incubated with the primary antibodies against GPX4 (#Ab125066, Abcam), SLC7A11 (#Ab175186, Abcam), ACSL4 (#Ab155282, Abcam), ZEB1 (#Sc- 515,797, Santa Cruz Biotechnology), E- cadherin (#20874- 1- AP, Proteintech), p- YAP (#29018- 1- AP, Proteintech) and p- NF2 (#28851- 1- AP, Proteintech) overnight at 4°C. ..

    Article Title: DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting Ferroptosis
    Article Snippet: .. The membranes were blocked with 5% skim milk at 37°C for 1 h and then incubated using primary antibodies against DDR1 (#SC‐374618, 1:1000, Santa Cruz Biotechnology, Dallas, USA), solute carrier family 7 member 11 (SLC7A11, #Ab175186, 1:1000, Abcam, Cambridge, UK), yes‐associated protein (YAP, #13584‐1‐AP, 1:2000, Proteintech, Rosemont, USA), p‐YAP (#29018‐1‐AP, 1:2000, Proteintech), acyl‐CoA synthetase long chain family member 4 (ACSL4, #Ab155282, 1:10000, Abcam), zinc finger E‐box binding homeobox 1 (ZEB1, #Sc‐515797, 1:1000, Santa Cruz Biotechnology), E‐cadherin (#20874‐1‐AP, 1:20000, Proteintech), glutathione peroxidase 4 (GPX4, #Ab125066, 1:1000, Abcam), neurofibromin 2 (NF2, #21686‐1‐AP, 1:2000, Proteintech), p‐NF2 (#28851‐1‐AP, 1:1000, Proteintech), HOXA6 (#18210‐1‐AP, 1:1000, Proteintech) and β‐actin (#66009–1‐Ig, 1:20000, Proteintech) overnight at 4°C. .. The following day, the blots were incubated with horseradish peroxidase (HRP)‐labelled secondary antibodies (#ab6728, #ab6721, #ab6741, 1:5000, Abcam) and visualised using an LAS‐4000 protein developing instrument (GE Healthcare, Pittsburgh, USA).

    Article Title: DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting Ferroptosis.
    Article Snippet: .. The membranes were blocked with 5% skim milk at 37°C for 1 h and then incubated using primary antibodies against DDR1 (#SC- 374618, 1:1000, Santa Cruz Biotechnology, Dallas, USA), solute carrier family 7 member 11 (SLC7A11, #Ab175186, 1:1000, Abcam, Cambridge, UK), yes- associated protein (YAP, #13584- 1- AP, 1:2000, Proteintech, Rosemont, USA), p- YAP (#29018- 1- AP, 1:2000, Proteintech), acyl- CoA synthetase long chain family member 4 (ACSL4, #Ab155282, 1:10000, Abcam), zinc finger E- box binding homeobox 1 (ZEB1, #Sc- 515797, 1:1000, Santa Cruz Biotechnology), Ecadherin (#20874- 1- AP, 1:20000, Proteintech), glutathione peroxidase 4 (GPX4, #Ab125066, 1:1000, Abcam), neurofibromin 2 (NF2, #21686- 1- AP, 1:2000, Proteintech), p- NF2 (#28851- 1- AP, 1:1000, Proteintech), HOXA6 (#18210- 1- AP, 1:1000, Proteintech) and β- actin (#66009–1- Ig, 1:20000, Proteintech) overnight at 4°C. .. The following day, the blots were incubated with horseradish peroxidase (HRP)- labelled secondary antibodies (#ab6728, #ab6721, #ab6741, 1:5000, Abcam) and visualised using an LAS- 4000 protein developing instrument (GE Healthcare, Pittsburgh, USA).

    Binding Assay:

    Article Title: DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting Ferroptosis
    Article Snippet: .. The membranes were blocked with 5% skim milk at 37°C for 1 h and then incubated using primary antibodies against DDR1 (#SC‐374618, 1:1000, Santa Cruz Biotechnology, Dallas, USA), solute carrier family 7 member 11 (SLC7A11, #Ab175186, 1:1000, Abcam, Cambridge, UK), yes‐associated protein (YAP, #13584‐1‐AP, 1:2000, Proteintech, Rosemont, USA), p‐YAP (#29018‐1‐AP, 1:2000, Proteintech), acyl‐CoA synthetase long chain family member 4 (ACSL4, #Ab155282, 1:10000, Abcam), zinc finger E‐box binding homeobox 1 (ZEB1, #Sc‐515797, 1:1000, Santa Cruz Biotechnology), E‐cadherin (#20874‐1‐AP, 1:20000, Proteintech), glutathione peroxidase 4 (GPX4, #Ab125066, 1:1000, Abcam), neurofibromin 2 (NF2, #21686‐1‐AP, 1:2000, Proteintech), p‐NF2 (#28851‐1‐AP, 1:1000, Proteintech), HOXA6 (#18210‐1‐AP, 1:1000, Proteintech) and β‐actin (#66009–1‐Ig, 1:20000, Proteintech) overnight at 4°C. .. The following day, the blots were incubated with horseradish peroxidase (HRP)‐labelled secondary antibodies (#ab6728, #ab6721, #ab6741, 1:5000, Abcam) and visualised using an LAS‐4000 protein developing instrument (GE Healthcare, Pittsburgh, USA).

    Article Title: DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting Ferroptosis.
    Article Snippet: .. The membranes were blocked with 5% skim milk at 37°C for 1 h and then incubated using primary antibodies against DDR1 (#SC- 374618, 1:1000, Santa Cruz Biotechnology, Dallas, USA), solute carrier family 7 member 11 (SLC7A11, #Ab175186, 1:1000, Abcam, Cambridge, UK), yes- associated protein (YAP, #13584- 1- AP, 1:2000, Proteintech, Rosemont, USA), p- YAP (#29018- 1- AP, 1:2000, Proteintech), acyl- CoA synthetase long chain family member 4 (ACSL4, #Ab155282, 1:10000, Abcam), zinc finger E- box binding homeobox 1 (ZEB1, #Sc- 515797, 1:1000, Santa Cruz Biotechnology), Ecadherin (#20874- 1- AP, 1:20000, Proteintech), glutathione peroxidase 4 (GPX4, #Ab125066, 1:1000, Abcam), neurofibromin 2 (NF2, #21686- 1- AP, 1:2000, Proteintech), p- NF2 (#28851- 1- AP, 1:1000, Proteintech), HOXA6 (#18210- 1- AP, 1:1000, Proteintech) and β- actin (#66009–1- Ig, 1:20000, Proteintech) overnight at 4°C. .. The following day, the blots were incubated with horseradish peroxidase (HRP)- labelled secondary antibodies (#ab6728, #ab6721, #ab6741, 1:5000, Abcam) and visualised using an LAS- 4000 protein developing instrument (GE Healthcare, Pittsburgh, USA).



    Similar Products

    1 ap proteintech rabbit anti p nf2  (Proteintech)
    93
    Proteintech 1 ap proteintech rabbit anti p nf2
    1 Ap Proteintech Rabbit Anti P Nf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+nf2/NF2+Antibody/pmc12361455__41419_2025_7962_MOESM4_ESM-18-81-82
    Average 93 stars, based on 1 article reviews
    1 ap proteintech rabbit anti p nf2 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    p nf2  (Proteintech)
    93
    Proteintech p nf2
    rPVL inhibited the phosphorylation of BCLAF1 S285 , CDK7 T170 , <t>NF2</t> S518 , and PKM2 S37 , whereas baicalin reversed the hypophosphorylation of these cell-cycle-related proteins induced by rPVL. ( A – D ) Representative immunofluorescence images of P-BCLAF1 S285 /P-CDK7 T170 /P-NF2 S518 /P-PKM2 S37 . ( E – H ) Quantification of immunofluorescence images. The results indicated that after rPVL treatment, the fluorescence intensity of the phosphorylated proteins described above decreased. However, when baicalin was administered prior to rPVL exposure, the inhibitory effect of rPVL on the phosphorylation of these cell-cycle-related proteins decreased, leading to an increase in fluorescence intensity. ( I ) The expression of cell-cycle-related proteins in BMECs was analyzed through Western blotting. ( J – M ) Western blot analysis revealed that the phosphorylation levels of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 decreased following rPVL treatment but increased after baicalin intervention. The asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001) indicate significant differences between groups.
    P Nf2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+nf2/NF2+Antibody/pmc12300862-63-5-26
    Average 93 stars, based on 1 article reviews
    p nf2 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    rabbit anti p nf2  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc rabbit anti p nf2
    rPVL inhibited the phosphorylation of BCLAF1 S285 , CDK7 T170 , <t>NF2</t> S518 , and PKM2 S37 , whereas baicalin reversed the hypophosphorylation of these cell-cycle-related proteins induced by rPVL. ( A – D ) Representative immunofluorescence images of P-BCLAF1 S285 /P-CDK7 T170 /P-NF2 S518 /P-PKM2 S37 . ( E – H ) Quantification of immunofluorescence images. The results indicated that after rPVL treatment, the fluorescence intensity of the phosphorylated proteins described above decreased. However, when baicalin was administered prior to rPVL exposure, the inhibitory effect of rPVL on the phosphorylation of these cell-cycle-related proteins decreased, leading to an increase in fluorescence intensity. ( I ) The expression of cell-cycle-related proteins in BMECs was analyzed through Western blotting. ( J – M ) Western blot analysis revealed that the phosphorylation levels of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 decreased following rPVL treatment but increased after baicalin intervention. The asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001) indicate significant differences between groups.
    Rabbit Anti P Nf2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+nf2/Phospho-Merlin+(Ser518)+Rabbit+mAb/pmc12035956-24-0-3
    Average 94 stars, based on 1 article reviews
    rabbit anti p nf2 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    p nf2  (Danaher Inc)
    86
    Danaher Inc p nf2
    rPVL inhibited the phosphorylation of BCLAF1 S285 , CDK7 T170 , <t>NF2</t> S518 , and PKM2 S37 , whereas baicalin reversed the hypophosphorylation of these cell-cycle-related proteins induced by rPVL. ( A – D ) Representative immunofluorescence images of P-BCLAF1 S285 /P-CDK7 T170 /P-NF2 S518 /P-PKM2 S37 . ( E – H ) Quantification of immunofluorescence images. The results indicated that after rPVL treatment, the fluorescence intensity of the phosphorylated proteins described above decreased. However, when baicalin was administered prior to rPVL exposure, the inhibitory effect of rPVL on the phosphorylation of these cell-cycle-related proteins decreased, leading to an increase in fluorescence intensity. ( I ) The expression of cell-cycle-related proteins in BMECs was analyzed through Western blotting. ( J – M ) Western blot analysis revealed that the phosphorylation levels of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 decreased following rPVL treatment but increased after baicalin intervention. The asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001) indicate significant differences between groups.
    P Nf2, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+nf2/pm37678441-48-26-29
    Average 86 stars, based on 1 article reviews
    p nf2 - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    rabbit anti-p-nf2/merlin s518 9163  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc rabbit anti-p-nf2/merlin s518 9163
    rPVL inhibited the phosphorylation of BCLAF1 S285 , CDK7 T170 , <t>NF2</t> S518 , and PKM2 S37 , whereas baicalin reversed the hypophosphorylation of these cell-cycle-related proteins induced by rPVL. ( A – D ) Representative immunofluorescence images of P-BCLAF1 S285 /P-CDK7 T170 /P-NF2 S518 /P-PKM2 S37 . ( E – H ) Quantification of immunofluorescence images. The results indicated that after rPVL treatment, the fluorescence intensity of the phosphorylated proteins described above decreased. However, when baicalin was administered prior to rPVL exposure, the inhibitory effect of rPVL on the phosphorylation of these cell-cycle-related proteins decreased, leading to an increase in fluorescence intensity. ( I ) The expression of cell-cycle-related proteins in BMECs was analyzed through Western blotting. ( J – M ) Western blot analysis revealed that the phosphorylation levels of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 decreased following rPVL treatment but increased after baicalin intervention. The asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001) indicate significant differences between groups.
    Rabbit Anti P Nf2/Merlin S518 9163, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/p+nf2/rabbit+anti+pnf2/pmc09114518-14-8-4
    Average 90 stars, based on 1 article reviews
    rabbit anti-p-nf2/merlin s518 9163 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    rPVL inhibited the phosphorylation of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 , whereas baicalin reversed the hypophosphorylation of these cell-cycle-related proteins induced by rPVL. ( A – D ) Representative immunofluorescence images of P-BCLAF1 S285 /P-CDK7 T170 /P-NF2 S518 /P-PKM2 S37 . ( E – H ) Quantification of immunofluorescence images. The results indicated that after rPVL treatment, the fluorescence intensity of the phosphorylated proteins described above decreased. However, when baicalin was administered prior to rPVL exposure, the inhibitory effect of rPVL on the phosphorylation of these cell-cycle-related proteins decreased, leading to an increase in fluorescence intensity. ( I ) The expression of cell-cycle-related proteins in BMECs was analyzed through Western blotting. ( J – M ) Western blot analysis revealed that the phosphorylation levels of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 decreased following rPVL treatment but increased after baicalin intervention. The asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001) indicate significant differences between groups.

    Journal: Microorganisms

    Article Title: Phosphoproteome Reveals the Role of Baicalin in Alleviating rPVL-Induced Cell Cycle Arrest in BMECs

    doi: 10.3390/microorganisms13071673

    Figure Lengend Snippet: rPVL inhibited the phosphorylation of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 , whereas baicalin reversed the hypophosphorylation of these cell-cycle-related proteins induced by rPVL. ( A – D ) Representative immunofluorescence images of P-BCLAF1 S285 /P-CDK7 T170 /P-NF2 S518 /P-PKM2 S37 . ( E – H ) Quantification of immunofluorescence images. The results indicated that after rPVL treatment, the fluorescence intensity of the phosphorylated proteins described above decreased. However, when baicalin was administered prior to rPVL exposure, the inhibitory effect of rPVL on the phosphorylation of these cell-cycle-related proteins decreased, leading to an increase in fluorescence intensity. ( I ) The expression of cell-cycle-related proteins in BMECs was analyzed through Western blotting. ( J – M ) Western blot analysis revealed that the phosphorylation levels of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 decreased following rPVL treatment but increased after baicalin intervention. The asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001) indicate significant differences between groups.

    Article Snippet: NF2 (1:7000, Cat. No. 21686–1-AP), P-NF2 (Ser518, 1:7000, Cat. No. 28851–1-AP), CDK7 (1:2800, Cat. No. 27027–1-AP), and PKM (1:2800, Cat. No. 10078–2-AP) antibodies were purchased from Proteintech (Rosemont, IL, USA).

    Techniques: Phospho-proteomics, Immunofluorescence, Fluorescence, Expressing, Western Blot

    Preemptive intervention with baicalin alleviated the pathological damage to mouse mammary tissue caused by rPVL and reversed the hypophosphorylation of cell cycle regulatory proteins induced by rPVL in the mammary tissue. ( A – F ) Histopathology of mammary tissue after infection with S. aureus and rPVL (400×). ( A ) Control (blank). ( B ) Control (0.9% NaCl). ( C ) S. aureus ATCC49775. ( D ) rPVL. ( E ) Bai+ S. aureus ATCC49775. ( F ) Bai+rPVL. The baicalin groups were administered 100 mg/kg baicalin. Arrows indicate inflammatory cells, triangles indicate macrophages, thick arrows point to eosinophils, and pentagrams highlight areas of papillary wall edema and thickening. ( K ) Representative immunohistochemical images of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 (400×). ( G – J ) The bar charts show the percentages of DAB-positive tissues. The asterisks and well numbers (* p < 0.05, ** p < 0.01, # p < 0.05, *** p < 0.001, ## p < 0.01, #### p < 0.0001 and ns p > 0.05) indicate significant changes in the expression of the above cell-cycle-regulating proteins in the rPVL-treated group compared with the vehicle group and in the baicalin-treated group compared with the rPVL-treated group, respectively.

    Journal: Microorganisms

    Article Title: Phosphoproteome Reveals the Role of Baicalin in Alleviating rPVL-Induced Cell Cycle Arrest in BMECs

    doi: 10.3390/microorganisms13071673

    Figure Lengend Snippet: Preemptive intervention with baicalin alleviated the pathological damage to mouse mammary tissue caused by rPVL and reversed the hypophosphorylation of cell cycle regulatory proteins induced by rPVL in the mammary tissue. ( A – F ) Histopathology of mammary tissue after infection with S. aureus and rPVL (400×). ( A ) Control (blank). ( B ) Control (0.9% NaCl). ( C ) S. aureus ATCC49775. ( D ) rPVL. ( E ) Bai+ S. aureus ATCC49775. ( F ) Bai+rPVL. The baicalin groups were administered 100 mg/kg baicalin. Arrows indicate inflammatory cells, triangles indicate macrophages, thick arrows point to eosinophils, and pentagrams highlight areas of papillary wall edema and thickening. ( K ) Representative immunohistochemical images of BCLAF1 S285 , CDK7 T170 , NF2 S518 , and PKM2 S37 (400×). ( G – J ) The bar charts show the percentages of DAB-positive tissues. The asterisks and well numbers (* p < 0.05, ** p < 0.01, # p < 0.05, *** p < 0.001, ## p < 0.01, #### p < 0.0001 and ns p > 0.05) indicate significant changes in the expression of the above cell-cycle-regulating proteins in the rPVL-treated group compared with the vehicle group and in the baicalin-treated group compared with the rPVL-treated group, respectively.

    Article Snippet: NF2 (1:7000, Cat. No. 21686–1-AP), P-NF2 (Ser518, 1:7000, Cat. No. 28851–1-AP), CDK7 (1:2800, Cat. No. 27027–1-AP), and PKM (1:2800, Cat. No. 10078–2-AP) antibodies were purchased from Proteintech (Rosemont, IL, USA).

    Techniques: Histopathology, Infection, Control, Immunohistochemical staining, Expressing